EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States

Wanjun Bai iD, Xue Sun, Bo Qiu, Caihui Guo, Haojing Song, Yiting Hu, Xueyuan Zhang, Peihua Yin, Xiaoru Wang, Zhanjun Dong

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s461771 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Wanjun Bai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China. Hauptthemen laut MEDLINE: Therapeutic Equivalency, Thalidomide, Fasting, Postprandial Period. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Therapeutic EquivalencyThalidomideFastingPostprandial PeriodCross-Over StudiesHealthy VolunteersTabletsHumansAdultMaleYoung AdultFemaleAnti-Inflammatory Agents, Non-SteroidalAsian PeopleArea Under CurveAdministration, Oral

Stichwörter der Autor:innen

apremilastbioequivalencepharmacokineticspsoriasissafety

Substanzen

ThalidomideapremilastTabletsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China.
  • Center for Clinical Pharmacology, Shanghai Innovstone Therapeutics Limited, Shanghai, People's Republic of China.
  • Center for Clinical Pharmacology, CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd, Shijiazhuang, People's Republic of China.

ORCID-Profile: Wanjun Bai

Zitieren

APA

Bai, W., Sun, X., Qiu, B., Guo, C., Song, H., Hu, Y., Zhang, X., Yin, P., Wang, X., & Dong, Z. (2024). Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s461771

Vancouver

Bai W, Sun X, Qiu B, Guo C, Song H, Hu Y, et al. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s461771

BibTeX
@article{Bai2024,
  author = {Bai, Wanjun and Sun, Xue and Qiu, Bo and Guo, Caihui and Song, Haojing and Hu, Yiting and Zhang, Xueyuan and Yin, Peihua and Wang, Xiaoru and Dong, Zhanjun},
  title = {Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s461771}
}
Kostenlos starten →